Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
20 April 2025
| Name: | ZENYTH THERAPEUTICS LIMITED (ZTL) | ||||||
| Date of Listing: | 05 December 1996 | ||||||
| Date of Delisting: | 17 November 2006 | ||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 17 November 2006.Legal Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | 07/12/2005 | |
| AMRAD CORPORATION LIMITED | 07/12/2005 |
REGISTRY:
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - CSL to acquire 100% of the issued shares in Zenyth - this corporate event may appear elsewhere in this company record | 17/11/2006 |
delisted following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited | 17/11/2006 |
we understand the consideration paid by CSL to Zenyth shareholders was $0.82 cash per Zenyth share - the cash consideration payable to Zenyth optionholders for each series of options (originally to be between $0.0100 and $0.5196 per Zenyth option, depending on the terms of the relevant Zenyth options) was increased to the higher of the value attributed to that series of options by the independent expert, Deloitte, and by Zenyth | 17/11/2006 |
securities suspended from quotation at the request of the Company in accordance with listing rule 17.2, following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited | 31/10/2006 |
name changed from Amrad Corporation Limited | 07/12/2005 |
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - CSL to acquire 100% of the issued shares in Zenyth - this corporate event may appear elsewhere in this company record | 17/11/2006 |
delisted following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited | 17/11/2006 |
we understand the consideration paid by CSL to Zenyth shareholders was $0.82 cash per Zenyth share - the cash consideration payable to Zenyth optionholders for each series of options (originally to be between $0.0100 and $0.5196 per Zenyth option, depending on the terms of the relevant Zenyth options) was increased to the higher of the value attributed to that series of options by the independent expert, Deloitte, and by Zenyth | 17/11/2006 |
securities suspended from quotation at the request of the Company in accordance with listing rule 17.2, following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited | 31/10/2006 |
name changed from Amrad Corporation Limited | 07/12/2005 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Ian Davis | Chairman | |
| Andrew Nash | CEO | |
| Alan Boyd | CFO | |
| Silviu Itescu | Non Exec Director | |
| Helen Cameron | Non Exec Director | |
| James MacKenzie | Non Exec Director | |
| Robyn Fry | General Counsel, Company Secretary |
Date of first appointment, title may have changed.
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
